Susquehanna Fundamental Investments’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60,527
| Closed | -$2.06M | – | 789 |
|
|
2025
Q1 | $2.06M | Sell |
60,527
-31,860
| -34% | -$1.08M | 0.03% | 521 |
|
|
2024
Q4 | $3.64M | Buy |
+92,387
| New | +$3.64M | 0.05% | 394 |
|
|
2024
Q2 | – | Sell |
-23,503
| Closed | -$1.6M | – | 946 |
|
|
2024
Q1 | $1.6M | Buy |
+23,503
| New | +$1.6M | 0.07% | 269 |
|
|
2022
Q4 | – | Sell |
-19,674
| Closed | -$1.29M | – | 1252 |
|
|
2022
Q3 | $1.29M | Buy |
+19,674
| New | +$1.29M | 0.02% | 718 |
|
|
2022
Q1 | $2M | Buy |
31,932
+10,120
| +46% | +$635K | 0.04% | 582 |
|
|
2021
Q4 | $1.65M | Buy |
21,812
+1,959
| +10% | +$148K | 0.04% | 485 |
|
|
2021
Q3 | $2.22M | Sell |
19,853
-2,867
| -13% | -$321K | 0.04% | 561 |
|
|
2021
Q2 | $3.68M | Buy |
+22,720
| New | +$3.68M | 0.07% | 397 |
|